Abstract
Summary
The influence of VDR gene for the risk of osteoporosis has remained inconclusive. VDR gene polymorphism in relation to BMD in postmenopausal women of Northwest India revealed a susceptibility haplotype AGT. Possession of this haplotype exacerbates the risk of osteoporosis by 2.8 times, which manifests in recessive mode of inheritance.
Purpose
The purpose of this study is to understand the influence of coordinated effect of various single nucleotide polymorphisms (SNPs) within vitamin D receptor (VDR) gene for the risk of osteoporosis, which has remained undefined so far.
Methods
Four pertinent SNPs of VDR gene, i.e., rs2228570, rs1544410, rs17879735, and rs731236 were examined with polymerase chain reaction–restriction fragment length polymorphism in dual energy X-ray absorptiometry verified 188 osteoporotics, 115 osteopenics, and 147 normal postmenopausal women of Northwest India.
Results
Minor allele ‘T’ of rs2228570 showed significant influence for the risk of osteoporosis (OR 1.60, 95%CI 1.16–2.20, P = 0.004) and also in dominant (OR 2.32, 95%CI 1.47–3.64, P = 0.0006) and additive model (OR 2.41, 95%CI 1.49–3.87, P = 0.0006) after Bonferroni correction. Minor allele (T) of rs2228570 showed an allele dose effect with BMD of L1-L4 (P = 0.009) and FN (P = 0.036). Disease association analysis exposed a susceptibility haplotype AGT which influences the risk of osteopenia (OR 2.04, 95%CI 1.03–4.08, P = 0.036) and osteoporosis (OR 2.90, 95%CI 1.61–5.38, P = 0.00005) after adjusting the effects of age, BMI and years since menopause. This haplotype is significantly associated with BMDs at lumbar spine (P = 0.0001) and femoral neck (P = 0.016).
Conclusion
In-depth analysis of this haplotype with other methods of Wald statistics and Akaike information criterion confirmed that carriers of each unit of this haplotype AGT increases the risk of osteoporosis by a factor of 2.80 ± 0.34 (β ± SE) which manifests (P = 0.1 × 10−6) in its recessive mode of inheritance.
Similar content being viewed by others
References
Kelly PJ, Morrison NA, Sambrook PN, Nguyen TV, Eisman JA (1995) Genetic influences on bone turnover, bone density and fracture. Eur J Endocrinol 133:265–271
Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S (1987) Genetic determinants of bone mass in adults. A twin study. J Clin Invest 80:706–710
Guéguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G (1995) Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 10:2017–2022
Yoshida T, Stern PH (2012) How vitamin D works on bone. Endocrinol Metab Clin N Am 41:557–569
Carlberg C, Molnar F (2012) Current status of vitamin D signaling and its therapeutic applications. Curr Top Med Chem 12:528–547
Turner AG, Anderson PH, Morris HA (2012) Vitamin D and bone health. Scand J Clin Lab Inv Suppl 243:65–72
Bouillon R, Okamura WH, Norman AW (1995) Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200–257
Miyamoto K, Kesterson RA, Yamamoto H et al (1997) Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol 11:1165–1179
Taymans SE, Pack S, Pak E et al (1999) The human vitamin D receptor gene (VDR) is localized to region 12cen-q12 by fluorescent in situ hybridization and radiation hybrid mapping: genetic and physical VDR map. J Bone Miner Res 14:1163–1166
Morrison NA, Qi JC, Tokita A et al (1994) Prediction of bone density from vitamin D receptor alleles. Nature 367:284–287
Sainz J, Van Tornout JM, Loro ML, Sayre J, Roe TF, Gilsanz V (1997) Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N Engl J Med 337:77–82
Kurabayashi T, Tomita M, Matsushita H et al (1999) Association of vitamin D and estrogen receptor gene polymorphism with the effect of hormone replacement therapy on bone mineral density in Japanese women. Am J Obstet Gynecol 180:1115–1120
Mencej-Bedrac S, Prezelj J, Kocjan T et al (2009) The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density. J Mol Endocrinol 42:239–247
Gong G, Stern HS, Cheng SC et al (1999) The association of bone mineral density with vitamin D receptor gene polymorphisms. Osteoporos Int 9:55–64
Thakkinstian A, D'Este C, Eisman J, Nguyen T, Attia J (2004) Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study. J Bone Miner Res 19:419–428
Thakkinstian A, D'Este C, Attia J (2004) Haplotype analysis of VDR gene polymorphisms: a meta-analysis. Osteoporos Int 15:729–734
Li Y, Xi B, Li K, Wang C (2012) Association between vitamin D receptor gene polymorphisms and bone mineral density in Chinese women. Mol Biol Rep 39:5709–5717
Fang Y, Rivadeneira F, van Meurs JB, Pols HA, Ioannidis JP, Uitterlinden AG (2006) Vitamin D receptor gene BsmI and TaqI polymorphisms and fracture risk: a meta-analysis. Bone 39:938–945
Uitterlinden AG, Ralston SH, Brandi ML et al (2006) The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med 145:255–264
Zintzaras E, Rodopoulou P, Koukoulis GN (2006) BsmI, TaqI, ApaI and FokI polymorphisms in the vitamin D receptor (VDR) gene and the risk of osteoporosis: a meta-analysis. Dis Markers 22:317–326
Qin G, Dong Z, Zeng P, Liu M, Liao X (2013) Association of vitamin D receptor BsmI gene polymorphism with risk of osteoporosis: a meta-analysis of 41 studies. Mol Biol Rep 40:497–506
Krishna U, Mehta RU (2000) Osteoporosis—incidence and implications. J Obstet Gynecol India 50:150–155
Johnell O, Gullberg B, Allander E et al (1992) The apparent incidence of hip fracture in Europe: a study of national register sources. MEDOS Study Group. Osteoporos Int 2:298–302
Gupta A (1998) Osteoporosis in India-the nutritional hypothesis. In: Metabolic bone disorders. Indian Society for Bone and Mineral Research, Eds: Mithal A, Rao DS, Zaidi M. 115–132
Cooper C, Campion G, Melton LJ 3rd (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289
Singh M, Singh P, Singh S, Juneja PK, Kaur T (2010) A susceptible haplotype within APOE gene influences BMD and intensifies the osteoporosis risk in postmenopausal women of Northwest India. Maturitas 67:239–244
World Health Organisation (WHO) (1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646–650
Long JR, Zhao LJ, Liu PY et al (2004) Patterns of linkage disequilibrium and haplotype distribution in disease candidate genes. BMC Genet 24:5–11
Sasieni PD (1997) From genotypes to genes: doubling the sample size. Biometrics 53:1253–1261
Excoffier L, Laval G, Schneider S (2007) Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 1:47–50
Akaike H (1987) Factor analysis and AIC. Psychometrika 52:317–332
Menashe I, Rosenberg PS, Chen BE (2008) PGA: power calculator for case–control genetic association analyses. BMC Genet 9:36
Devlin B, Roeder K (1999) Genomic control for association studies. Biometrics 55:997–1004
Mitra S, Desai M, Ikram Khatkhatay M (2006) Vitamin D receptor gene polymorphisms and bone mineral density in postmenopausal Indian women. Maturitas 55:27–35
Gennari L, Becherini L, Masi L et al (1998) Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density. J Clin Endocrinol Metab 83:939–944
Singh M, Singh P, Juneja PK, Singh S, Kaur T (2011) SNP-SNP interactions within APOE gene influence plasma lipids in postmenopausal osteoporosis. Rheumatol Int 31:421–423
Rubin LA, Hawker GA, Peltekova VD, Fielding LJ, Ridout R, Cole DE (1999) Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort. J Bone Miner Res 14:633–643
Douroudis K, Tarassi K, Ioannidis G et al (2003) Association of vitamin D receptor gene polymorphisms with bone mineral density in postmenopausal women of Hellenic origin. Maturitas 45:191–197
Colin EM, Uitterlinden AG, Meurs JB et al (2003) Interaction between vitamin D receptor genotype and estrogen receptor alpha genotype influences vertebral fracture risk. J Clin Endocrinol Metab 88:3777–3784
Uitterlinden AG, Weel AE, Burger H et al (2001) Interaction between the vitamin D receptor gene and collagen type Ialpha1 gene in susceptibility for fracture. J Bone Miner Res 16:379–385
Grundberg E, Lau EM, Pastinen T, Kindmark A et al (2007) Vitamin D receptor 3′ haplotypes are unequally expressed in primary human bone cells and associated with increased fracture risk: the MrOS Study in Sweden and Hong Kong. J Bone Miner Res 22:832–840
Acknowledgments
The financial support of the DST project (SR/WOS-A/LS-225/2007) to MS is highly acknowledged.
Role of Funding Source
The present study is a part of the major research project (SR/WOS-A/LS-225/2007) funded by department of Science and Technology (DST), New Delhi to Dr. Monica Singh. The funding agency had no role in the design, collection, analysis and interpretation of data; in the writing of the report and in the decision to submit the paper for publication.
Conflicts of Interest
None.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 47 kb)
Rights and permissions
About this article
Cite this article
Singh, M., Singh, P., Singh, S. et al. Vitamin D receptor (VDR) gene polymorphism influences the risk of osteoporosis in postmenopausal women of Northwest India. Arch Osteoporos 8, 147 (2013). https://doi.org/10.1007/s11657-013-0147-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11657-013-0147-y